Bifidobacterium Lactis (BB-12/HN019)
One of the most studied probiotic species. HN019 speeds up gut transit in constipated adults in dose-ranging and multicenter trials; the effect is consistent but measured in hours, not days.
Evidence last reviewed: August 2026
What the science says
- Faster colonic transit Moderate evidence
A double-blind, randomized, dose-ranging trial found that 28 days of B. lactis HN019 shortened colonic transit time in adults with functional constipation and reduced some GI symptoms. A meta-analysis of randomized trials confirms that probiotic supplementation shortens intestinal transit by roughly half a day on average, with bifidobacteria among the better performers.
- Functional constipation symptoms Moderate evidence
A multi-center, triple-blind, randomized, placebo-controlled trial of 8 weeks of HN019 in functional constipation reported improvement in bowel habit outcomes, though effect sizes were modest.
- Immune markers Limited evidence
Trials in older adults report increases in phagocytic activity and other laboratory immune measures, without demonstrating fewer infections.
Dosage & safety
Scientific references
- Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: A double-blind, randomized, placebo-controlled, and dose-ranging trial
- Probiotic supplementation decreases intestinal transit time: meta-analysis of randomized controlled trials
- Effect of an 8-Week Bifidobacterium lactis HN019 Supplementation on Functional Constipation: A Multi-Center, Triple-Blind, Randomized, Placebo-Controlled Trial
Where to buy
Ships to 180+ countries · welcome discount for new customers
Referral link — this site may earn a commission on purchases.
Related in Gut health
- Probiotics Moderate evidence
- Psyllium Husk (fiber) Strong evidence
- L-Glutamine Limited evidence
- Oregano Oil Limited evidence
- Ginger Moderate evidence
- Inulin (Prebiotic Fiber) Moderate evidence